Review



v(d)j gene fragments of antibodies 2f5, ch65  (GenScript corporation)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    GenScript corporation v(d)j gene fragments of antibodies 2f5, ch65
    (A) ELISA binding of 2F5 to the HIV-1 gp41 peptide SP62 that includes the 2F5 epitope (red), SP62 Mut (red dashed), KYNU (blue) and mutKYNU (blue dashed). (B) In vitro KYNU enzymatic assay measuring levels of 3-hydroxyanthranilic acid being converted by kynureninase from 3-hydroxykynurenine measured as RFU over time with the addition of KYNU, mutKYNU, substrate alone and buffer alone. Sequences of KYNU and mutKYNU that were tested in the in vitro KYNU enzymatic assay. Vmax and specific activity of wild-type KYNU and mutKYNU in the in vitro KYNU enzymatic assay using 0.2μg of each enzyme (C-F) KYNU enzymatic assay by adding increasing amounts of (C) polyclonal α-KYNU antibody (D) <t>CH65</t> antibody (E) 2F5 antibody or (F) 2F5 antibody with mutKYNU enzyme.
    V(d)j Gene Fragments Of Antibodies 2f5, Ch65, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/v(d)j gene fragments of antibodies 2f5, ch65/product/GenScript corporation
    Average 90 stars, based on 1 article reviews
    v(d)j gene fragments of antibodies 2f5, ch65 - by Bioz Stars, 2026-06
    90/100 stars

    Images

    1) Product Images from "HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism"

    Article Title: HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism

    Journal: Journal of immunology (Baltimore, Md. : 1950)

    doi: 10.4049/jimmunol.1601484

    (A) ELISA binding of 2F5 to the HIV-1 gp41 peptide SP62 that includes the 2F5 epitope (red), SP62 Mut (red dashed), KYNU (blue) and mutKYNU (blue dashed). (B) In vitro KYNU enzymatic assay measuring levels of 3-hydroxyanthranilic acid being converted by kynureninase from 3-hydroxykynurenine measured as RFU over time with the addition of KYNU, mutKYNU, substrate alone and buffer alone. Sequences of KYNU and mutKYNU that were tested in the in vitro KYNU enzymatic assay. Vmax and specific activity of wild-type KYNU and mutKYNU in the in vitro KYNU enzymatic assay using 0.2μg of each enzyme (C-F) KYNU enzymatic assay by adding increasing amounts of (C) polyclonal α-KYNU antibody (D) CH65 antibody (E) 2F5 antibody or (F) 2F5 antibody with mutKYNU enzyme.
    Figure Legend Snippet: (A) ELISA binding of 2F5 to the HIV-1 gp41 peptide SP62 that includes the 2F5 epitope (red), SP62 Mut (red dashed), KYNU (blue) and mutKYNU (blue dashed). (B) In vitro KYNU enzymatic assay measuring levels of 3-hydroxyanthranilic acid being converted by kynureninase from 3-hydroxykynurenine measured as RFU over time with the addition of KYNU, mutKYNU, substrate alone and buffer alone. Sequences of KYNU and mutKYNU that were tested in the in vitro KYNU enzymatic assay. Vmax and specific activity of wild-type KYNU and mutKYNU in the in vitro KYNU enzymatic assay using 0.2μg of each enzyme (C-F) KYNU enzymatic assay by adding increasing amounts of (C) polyclonal α-KYNU antibody (D) CH65 antibody (E) 2F5 antibody or (F) 2F5 antibody with mutKYNU enzyme.

    Techniques Used: Enzyme-linked Immunosorbent Assay, Binding Assay, In Vitro, Enzymatic Assay, Activity Assay



    Similar Products

    v(d)j gene fragments of antibodies 2f5, ch65  (GenScript corporation)
    90
    GenScript corporation v(d)j gene fragments of antibodies 2f5, ch65
    (A) ELISA binding of 2F5 to the HIV-1 gp41 peptide SP62 that includes the 2F5 epitope (red), SP62 Mut (red dashed), KYNU (blue) and mutKYNU (blue dashed). (B) In vitro KYNU enzymatic assay measuring levels of 3-hydroxyanthranilic acid being converted by kynureninase from 3-hydroxykynurenine measured as RFU over time with the addition of KYNU, mutKYNU, substrate alone and buffer alone. Sequences of KYNU and mutKYNU that were tested in the in vitro KYNU enzymatic assay. Vmax and specific activity of wild-type KYNU and mutKYNU in the in vitro KYNU enzymatic assay using 0.2μg of each enzyme (C-F) KYNU enzymatic assay by adding increasing amounts of (C) polyclonal α-KYNU antibody (D) <t>CH65</t> antibody (E) 2F5 antibody or (F) 2F5 antibody with mutKYNU enzyme.
    V(d)j Gene Fragments Of Antibodies 2f5, Ch65, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/v(d)j gene fragments of antibodies 2f5, ch65/product/GenScript corporation
    Average 90 stars, based on 1 article reviews
    v(d)j gene fragments of antibodies 2f5, ch65 - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    v(d)j gene fragments  (GenScript corporation)
    90
    GenScript corporation v(d)j gene fragments
    (A) ELISA binding of 2F5 to the HIV-1 gp41 peptide SP62 that includes the 2F5 epitope (red), SP62 Mut (red dashed), KYNU (blue) and mutKYNU (blue dashed). (B) In vitro KYNU enzymatic assay measuring levels of 3-hydroxyanthranilic acid being converted by kynureninase from 3-hydroxykynurenine measured as RFU over time with the addition of KYNU, mutKYNU, substrate alone and buffer alone. Sequences of KYNU and mutKYNU that were tested in the in vitro KYNU enzymatic assay. Vmax and specific activity of wild-type KYNU and mutKYNU in the in vitro KYNU enzymatic assay using 0.2μg of each enzyme (C-F) KYNU enzymatic assay by adding increasing amounts of (C) polyclonal α-KYNU antibody (D) <t>CH65</t> antibody (E) 2F5 antibody or (F) 2F5 antibody with mutKYNU enzyme.
    V(d)j Gene Fragments, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/v(d)j gene fragments/product/GenScript corporation
    Average 90 stars, based on 1 article reviews
    v(d)j gene fragments - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) ELISA binding of 2F5 to the HIV-1 gp41 peptide SP62 that includes the 2F5 epitope (red), SP62 Mut (red dashed), KYNU (blue) and mutKYNU (blue dashed). (B) In vitro KYNU enzymatic assay measuring levels of 3-hydroxyanthranilic acid being converted by kynureninase from 3-hydroxykynurenine measured as RFU over time with the addition of KYNU, mutKYNU, substrate alone and buffer alone. Sequences of KYNU and mutKYNU that were tested in the in vitro KYNU enzymatic assay. Vmax and specific activity of wild-type KYNU and mutKYNU in the in vitro KYNU enzymatic assay using 0.2μg of each enzyme (C-F) KYNU enzymatic assay by adding increasing amounts of (C) polyclonal α-KYNU antibody (D) CH65 antibody (E) 2F5 antibody or (F) 2F5 antibody with mutKYNU enzyme.

    Journal: Journal of immunology (Baltimore, Md. : 1950)

    Article Title: HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism

    doi: 10.4049/jimmunol.1601484

    Figure Lengend Snippet: (A) ELISA binding of 2F5 to the HIV-1 gp41 peptide SP62 that includes the 2F5 epitope (red), SP62 Mut (red dashed), KYNU (blue) and mutKYNU (blue dashed). (B) In vitro KYNU enzymatic assay measuring levels of 3-hydroxyanthranilic acid being converted by kynureninase from 3-hydroxykynurenine measured as RFU over time with the addition of KYNU, mutKYNU, substrate alone and buffer alone. Sequences of KYNU and mutKYNU that were tested in the in vitro KYNU enzymatic assay. Vmax and specific activity of wild-type KYNU and mutKYNU in the in vitro KYNU enzymatic assay using 0.2μg of each enzyme (C-F) KYNU enzymatic assay by adding increasing amounts of (C) polyclonal α-KYNU antibody (D) CH65 antibody (E) 2F5 antibody or (F) 2F5 antibody with mutKYNU enzyme.

    Article Snippet: Polyclonal anti-KYNU antibody was purchased (rndsystems #AF4887) and the V(D)J gene fragments of antibodies 2F5, CH65 were synthesized and cloned (GenScript) into plasmids containing human or rhesus IgG1/IgK/IgL constant regions.

    Techniques: Enzyme-linked Immunosorbent Assay, Binding Assay, In Vitro, Enzymatic Assay, Activity Assay